ISABEL
CASTREJÓN FERNÁNDEZ
Profesora asociada
Hospital Universitario Virgen Macarena
Sevilla, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario Virgen Macarena (7)
2024
-
Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry
Arthritis Research and Therapy, Vol. 26, Núm. 1
-
Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry
Annals of the Rheumatic Diseases, Vol. 83, Núm. 9, pp. 1189-1199
-
Real-world persistence of initial targeted therapy strategy in monotherapy versus combination therapy in patients with chronic inflammatory arthritis
European Journal of Clinical Investigation, Vol. 54, Núm. 2
2023
-
Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study
RMD open, Vol. 9, Núm. 1
-
Gender biases in Spanish rheumatology: Perception and facts
Reumatologia Clinica, Vol. 19, Núm. 7, pp. 392-401
-
Proposal for updating the Health Assessment Questionnaire
Reumatologia Clinica, Vol. 19, Núm. 5, pp. 266-272
2022
-
Retention of golimumab treatment following discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases: An analysis of the Spanish BIOBADASER registry
Musculoskeletal Care, Vol. 20, Núm. 2, pp. 403-407